Gene Solutions Debuts ctDNA Oncology Portfolio in Türkiye
Gene Solutions announced its entry into the Turkish market at the 2nd International Hereditary Cancers Congress (IHCC) held Feb. 5–8, 2026 in Antalya, partnering with ATC Genomics to present RWE from one of Asia’s largest cohorts (n=12,281) evaluating its SPOT-MAS multi-cancer early detection assay. The company highlighted clinical performance—sensitivity ~78.2%, specificity 99.8%, tumor-of-origin ~82%—and showcased K-4CARE genomic/transcriptomic profiling and MRD monitoring for high-risk populations.
Scoring Rationale
Strong clinical RWE and peer-reviewed validation drive credibility; commercial rollout and limited methodological innovation constrain impact.
Practice interview problems based on real data
1,500+ SQL & Python problems across 15 industry datasets — the exact type of data you work with.
Try 250 free problemsStep-by-step roadmaps from zero to job-ready — curated courses, salary data, and the exact learning order that gets you hired.
Sources
- Read OriginalGene Solutions Announces Strategic Entry into Türkiye with Robust Real-World Evidenceen.antaranews.com
